Analysis
The associations between adherence and changes in PACQLQ, FeNO and
symptom control from baseline to the end of the monitoring period were
assessed using the non-parametric Wilcoxon Signed Rank Test, differences
between unpaired data were assessed using the Mann Whitney test for 2
groups, or the Kruskal Wallis test for >2 groups. Data were
analysed using Graphpad Prism v6 software and p<0.05 was
considered statistically significant.